|
Volumn 11, Issue 3, 2005, Pages 490-493
|
Management of diabetic foot in a Jordanian hospital
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMIKACIN;
ANTIBIOTIC AGENT;
CEFTAZIDIME;
IMIPENEM;
LINCOMYCIN;
METRONIDAZOLE;
PIPERACILLIN PLUS TAZOBACTAM;
ANTIBIOTIC THERAPY;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIABETIC FOOT;
DISEASE CLASSIFICATION;
FOOT AMPUTATION;
HOSPITALIZATION;
HUMAN;
JORDAN;
KIDNEY DYSFUNCTION;
MAJOR CLINICAL STUDY;
POSTOPERATIVE INFECTION;
RANDOMIZED CONTROLLED TRIAL;
SEPTICEMIA;
TREATMENT OUTCOME;
AMIKACIN;
AMPUTATION;
ANTI-BACTERIAL AGENTS;
CEFTAZIDIME;
CHEMOTHERAPY, ADJUVANT;
DEBRIDEMENT;
DIABETIC FOOT;
DRUG COMBINATIONS;
DRUG MONITORING;
HUMANS;
IMIPENEM;
KIDNEY DISEASES;
LENGTH OF STAY;
LINCOMYCIN;
METRONIDAZOLE;
PATIENT SELECTION;
PENICILLANIC ACID;
PIPERACILLIN;
SEPSIS;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
WOUND HEALING;
WOUND INFECTION;
|
EID: 33645319966
PISSN: 10203397
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (8)
|